RESUMO
Age-related eye diseases are a series of ophthalmic diseases caused by degenerative disease of ocular tissues, and age-related macular degeneration(ARMD), age-related cataract(ARC), diabetic retinopathy(DR)and glaucoma are the four most common age-related eye diseases. With the increasing aging of the global social population, the incidence of these eye diseases is also increasing year by year. Metformin is currently one of the most commonly used hypoglycemic agents in clinical practice. It has become the drug of choice for treating type 2 diabetes after more than 60 years of clinical practice. In recent years, metformin has shown great potential in the prevention and treatment of tumors, systemic diseases and age-related diseases, and the mechanisms of action involved in anti-oxidative stress, anti-inflammation, and induction of autophagy are also closely related to the pathological changes of age-related eye diseases. The paper aims to review the current research status and potential application value of metformin in age-related eye diseases.
RESUMO
Age-related eye diseases are a set of ophthalmic diseases caused by aging and irreversible degeneration in the eye.Glaucoma,cataract,and age-related macular degeneration (AMD) are some of the common age-related eye diseases.Inflammation and oxidative stress play important roles in the initiation and progression of these diseases.Resveratrol,a natural plant antitoxin,fights oxidative stress and inflammation by regulating multiple cellular transduction pathways;and it has become a focal point in anti-aging research and has seen significant research progress during recent years.At the present,investigation into the relationship between resveratrol and age-related eye diseases is still in its infancy.This paper focuses on elaborating new research progress on resveratrol's role in age-related eye diseases.